In addition to HER2-positive breast cancer, increasing attention has been given to HER2-low breast cancer, a newly recognized category characterized by HER2 IHC scores of 1+ or 2+ without gene amplification [39,40]. The gene discussed is ERBB2; the disease is breast carcinoma.